Prevalency of Enterococcus faecalis and Enterococcus faecium with high-level resistance to aminoglycosides in the cities of Resistencia and Corrientes, República Argentina;Prevalencia de Enterococcus faecalis y Enterococcus faecium con resistencia de alto nivel a aminoglucósidos en las ciudades de Resistencia y Corrientes, República Argentina

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 18, Issue 2, 2000, Pages 71-73

  Ronconi, María Cristina ^a,b   Merino, Luis Antonio ^a  

^a UNIVERSIDAD NACIONAL DEL NORDESTE   (Argentina)

^b NONE   (Argentina)

Author keywords

Aminoglycosides; Antimicrobial resistance; Enterococcus

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; GENTAMICIN; KANAMYCIN; STREPTOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARGENTINA; ARTICLE; CITY; DRUG DISTRIBUTION; ENTEROCOCCUS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; NONHUMAN;

AMINOGLYCOSIDES; ARGENTINA; DRUG RESISTANCE, MICROBIAL; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; GENTAMICINS; HUMANS; PREVALENCE; URBAN HEALTH;

EID: 0034050284     PISSN: 0213005X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Giglio Maira MS, Pinto Claude ME, Córdoba JE, Escandar DP, Waman MC. Identification of enterococcus species from clinical samples and susceptibility antimicrobial agents. Rew Med Chile 1996; 124: 70-76.
2. Tripodi MF, Utili R, Rambaldi A, Locatelli A, Rosario P, Florio A et al. Unortodox antibiotic combinations including ciprofloxacin against high-level gentamicin resistant enterococci. J Antimicrob Chemother 1996; 37: 727-736.
3. a ed.). Washington, D.C.: American Society for Microbiology, 1985; 154-175.
4. a ed.). NCCLS Documents M2-A6, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania, 1997.
5. Rossi MA. Módulo Antimicrobianos. Curso de Microbiología Clínica. Santa Fe, Argentina: Asociación Argentina de Microbiología, 1997.
6. Horodniceanu T, Bougueleret L, El-Solh N, Bieth G, Delbos F. High-level, plasmid-borne resistance to gentamicin in Streptococcus faecalis subsp. Zimogenes. Antimicrob Agents Chemother 1979; 16: 686-689.
7. Bantar C, Rojas A, Relloso S, Smayeusky J, Bianchini H. Identification of Enterococcus spp. in clinical samples. Incidence of high-level resistance to aminoglycosides. Infect Microbiol Clin 1991; 3: 84-89.
8. nd General Meeting del American Society for Microbiology. New Orleans. Infec Microbiol Clin 1993; 3: 33-34.
9. Pedari SC, Gutiérrez MA, Ribas C, Molinari GS, Santoianni JE. Susceptibility of E. faecalis to twelve antibiotics, time kills assays, and high level aminoglycoside resistance in a university hospital in Argentina. Rev Argent Microb 1991; 23: 67-78.
10. Giney M, Urwin G. Frequency and antimicrobial susceptibility of clinical isolates of enterococci. Eur J Clin Microbiol Infect Dis 1993; 12: 362-366.
11. McNamara EB, King EM, Smyth EG. A survey of antimicrobial susceptibility of clinical isolates of Enterococcus spp. from Irish hospitals. J Antimicrob Chemoter 1995; 35: 185-189.
12. Del Valle Ortiz O, Gallés C, Codina G, Cano A. Enterococos: alto nivel de resistencia a aminoglucósidos. Enferm Infecc Microbiol Clin 1989; 7: 535-541.
13. Balas D, Perea B, Wilhelmi I, Romanyk J, Alós JL, Gómez Garces JL. Prevalencia antimicrobiana de enterococos aislados en sangre en Madrid (1994-1995). Enferm Infecc Microbiol Clin 1997; 13: 22-23.
14. Caballero Granado FJ, Cisneros JM, Luque R, Torres-Tortosa M, Gamboa F, Díez F et al. Comparative study of bacterihemias caused by Enterococcus spp. with and without high level resistance to gentamicine. The Grupo Andaluz para el Estudio de las Enfermedades Infecciosas. J Clin Microbiol 1998; 36: 520-525.